Home/Pipeline/MDXX‑1

MDXX‑1

Post‑Traumatic Stress Disorder

PreclinicalActive

Key Facts

Indication
Post‑Traumatic Stress Disorder
Phase
Preclinical
Status
Active
Company

About PharmAla Biotech

Canada’s sole GMP‑grade MDMA supplier, advancing safe MDXX drug candidates for mental‑health therapeutics.

View full company profile

Other Post‑Traumatic Stress Disorder Drugs

DrugCompanyPhase
MDMAShields PharmaPreclinical